UBE3A is a gene implicated in neurodevelopmental disorders. The protein product of UBE3A is the E3 ligase E6-associated protein (E6AP), and its expression in the brain is uniquely regulated via genetic imprinting. Loss of E6AP expression leads to the development of Angelman syndrome (AS), clinically characterized by lack of speech, abnormal motor development, and the presence of seizures. Conversely, copy number variations (CNVs) that result in the overexpression of E6AP are strongly associated with the development of autism spectrum disorders (ASDs), defined by decreased communication, impaired social interest, and increased repetitive behavior. In this review article, we focus on the neurobiological function of Ube3A/E6AP. As an E3 ligase...
Angelman syndrome (AS) is a neurodevelopmental disorder first described by Harry Angelman in 1965 [8...
Angelman Syndrome (AS) is a devastating neurodevelopmental disorder characterized by developmental d...
Angelman Syndrome (AS) is a severe neurodevelopmental disorder that affects 1:12000 newborns. It is ...
UBE3A is a dual function protein consisting of ubiquitin ligase as well as transcriptional co-activa...
Angelman syndrome (AS) is a complex genetic disorder that affects the nervous system. AS affects an ...
This report is a meeting summary of the 2010 Angelman Syndrome Foundation's scientific symposium on ...
SummaryAngelman Syndrome is a debilitating neurological disorder caused by mutation of the E3 ubiqui...
Angelman syndrome (AS) is a severe genetic disorder caused by mutations or deletions of the maternal...
UBE3A is a protein with dual functions as an E3 ubiquitin ligase and as a Steroid Hormone Receptor (...
UBE3A is an E3 ubiquitin ligase encoded by an imprinted gene whose maternal deletion or duplication ...
Angelman Syndrome is a debilitating neurological disorder caused by mutation of the E3 ubiquitin lig...
Deletion of UBE3A causes the neurodevelopmental disorder Angelman syndrome (AS) while duplication or...
Half a century ago, Harry Angelman reported three patients with overlapping clinical features, now w...
In this review we summarize the clinical and genetic aspects of Angelman syndrome (AS), its molecula...
Angelman syndrome (AS) is a rare genetic disorder characterized by severe intellectual disability, s...
Angelman syndrome (AS) is a neurodevelopmental disorder first described by Harry Angelman in 1965 [8...
Angelman Syndrome (AS) is a devastating neurodevelopmental disorder characterized by developmental d...
Angelman Syndrome (AS) is a severe neurodevelopmental disorder that affects 1:12000 newborns. It is ...
UBE3A is a dual function protein consisting of ubiquitin ligase as well as transcriptional co-activa...
Angelman syndrome (AS) is a complex genetic disorder that affects the nervous system. AS affects an ...
This report is a meeting summary of the 2010 Angelman Syndrome Foundation's scientific symposium on ...
SummaryAngelman Syndrome is a debilitating neurological disorder caused by mutation of the E3 ubiqui...
Angelman syndrome (AS) is a severe genetic disorder caused by mutations or deletions of the maternal...
UBE3A is a protein with dual functions as an E3 ubiquitin ligase and as a Steroid Hormone Receptor (...
UBE3A is an E3 ubiquitin ligase encoded by an imprinted gene whose maternal deletion or duplication ...
Angelman Syndrome is a debilitating neurological disorder caused by mutation of the E3 ubiquitin lig...
Deletion of UBE3A causes the neurodevelopmental disorder Angelman syndrome (AS) while duplication or...
Half a century ago, Harry Angelman reported three patients with overlapping clinical features, now w...
In this review we summarize the clinical and genetic aspects of Angelman syndrome (AS), its molecula...
Angelman syndrome (AS) is a rare genetic disorder characterized by severe intellectual disability, s...
Angelman syndrome (AS) is a neurodevelopmental disorder first described by Harry Angelman in 1965 [8...
Angelman Syndrome (AS) is a devastating neurodevelopmental disorder characterized by developmental d...
Angelman Syndrome (AS) is a severe neurodevelopmental disorder that affects 1:12000 newborns. It is ...